post-marketing 第1页

Establishment of model of traditional Chinese medicine injections post-marketing safety monitoring Exploration of how to formulate guidelines on post-marketing traditional Chinese medicine surveillance Analysis of clinical use of post-marketing hospital centralized monitoring of Xiyanping injection Opportunity and challenge of post-marketing evaluation of traditional Chinese medicine Taking evaluation of post-marketing as point of cut-in to promote systematic research of traditional Chinese medicine Clinical safety re-evaluation of post-marketing Chinese materia medica on syndrome “Re-evaluation upon suspected event” is an approach for post-marketing clinical study： lessons from adverse drug events related to Bupleuri Radix preparations Post-marketing re-evaluation of Kudiezi injection study on early treatment in patients with ischemic stroke Post-marketed re-evaluation of fleabane injection and Dengzhan Shengmai capsule study on treatment in patients with ischemic stroke Study on 10 409 cases of post-marketing safety Danhong injection centralized monitoring of hospital Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world Thought on several problems of post-marketing herbs clinical evaluation in special populations Basic requirements on post-marketing clinical re-evaluation of Chinese medicine and phase Ⅳ clinical trials Process and key points of clinical literature evaluation of post-marketing traditional Chinese medicine Application of Markov model in post-marketing pharmacoeconomic evaluation of traditional Chinese medicine Research about re-evaluation of screening of traditonal Chinese medicine symptoms item of post-marketing medicine Xuezhikang Application of regular expression in extracting key information from Chinese medicine literatures about re-evaluation of post-marketing surveillance Post-marketing reevaluation for potential quality risk and quality control in clinical application of traditional Chinese medicines Sample size calculation in clinical post-marketing evaluation of traditional Chinese medicine Post-marketing clinical study of traditional Chinese medicine——lessons learned from comprehensive evaluation of Fufang Zaoren capsule Expert consensus post-marketing evaluation scheme to detect immunotoxicity of Chinese medicine in clinical populations (draft version for comments) Technical specifications for post-marketing pharmacoeconomic evaluation of Chinese medicine(draft version for comments) Technical specifications for intensive hospital safety monitoring of post-marketing Chinese medicine(draft version for comments) Clinical effect of Kudiezi injection on renal function based on propensity score Establish research model of post-marketing clinical safety evaluation for Chinese patent medicine Methodology on revaluation of syndrome therapeutic effect of post-marketing Chinese materia medica Survey on Xiaoke pill treating diabetes mellitus in small cities‘ Chinese medicine hospital for post-marketing surveillance Literature review of post-marketing clinical evaluation of Xiaoke pill